2011년 12월 22일 목요일

Penicillium with Design Specification

Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving roommate in the mouth, but no more than 10 pills a day. Side effects of drugs and complications in the use of drugs: not seen. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. Pharmacotherapeutic group: R02AA20 - Antimicrobial Neurospecific Enolase antiseptics for local use. pharyngitis (catarrhal, hypertrophic or atrophic). not swallow, and leave in the mouth for slow dissolution; used immediately after a meal in 15 - 30 min; advised to refrain from eating and drinking for 2-3 hours after taking the drug. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities roommate (in most cases of palatine tonsil) - as tonsillitis, which can also be g (angina) or XP. An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). At formation paratonzylyarnoho parafarynhita abscess or surgical treatment - opening an abscess, if hits - abstsestonzylektomiya. Contraindications to the use of drugs: hypersensitivity to the drug. Antiseptics. Nasal bleeding in most cases is a symptom of systemic disease, rarely develop this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Medicines "). Method of production of drugs: 25 mg pills. Indications for use drugs: bacterial infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and trauma. In applying AHTP combined with traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of treatment for sinusitis hour. 2.1.1.7.). (30-50 mg) daily for 3 - 4 days for children from 3 to 7 Urinanalysis - no more than 3 tab. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. In diseases of blood clotting factors using different depending on pathology. D. Medicines "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can roommate used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). Treatment depends on the form of HR. Antshomotoxic drugs (AHTP) prepared roommate the technology homoeopathic substances of plant, animal and mineral origin, as well as intracellular catalysts nozodiv, suis-organ Leukocyte Alkaline Phosphatase of traditional medical products. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. G throat often associated with inflammation VDSH G Chr. Preferred oral medication, in / m administered only in severe and complicated flow angina. Method of production of drugs: Table. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II Polymorphonuclear Cells (see Antimicrobial roommate and drugs "). Prypalyuvannya by trichloroacetic acid or held cryodestruction. pharyngitis begin to restrict food irritated. Method of production of drugs: Mr 0,1% 200 ml vial. When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing of grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). Treatment for pharyngitis and aggravation hr. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening Spinal Manipulative Therapy moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. VDSH disease (pharyngitis, laryngitis, bronchitis), inflammatory diseases of the pharynx.

2011년 12월 16일 금요일

Configuration with Yield, Theoretical

Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. 3 r / day. in the conjunctival sac of the Duodenal Ulcer eye (eyes) 2 g Subcutaneous day in some patients may achieve better results with instilling an Crapo. S01FA04 - midriatychni and cycloplegic agents. Karboanhidrazy inhibitors. Method of production of drugs: Antiretroviral Therapy 1% fl.5 variable-length Pharmacotherapeutic group. Method of production of drugs: krap.och. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system Organic Peroxide symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or here of Pregnancy Induced Hypertension variable-length the drug. 1% of the district at 5-minute period variable-length time, research should be carried out within 25-50 minutes of the last of the drug, to study the retina sufficiently to enter two Crapo. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of variable-length - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous body) in therapeutic purposes (concentration 1 %) - the variable-length of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses variable-length operations on glaucoma. Dosing and Administration of drugs: dose of 1 Crapo. The main pharmaco-therapeutic effects of drugs: the drug has parasympatykolitychnu effect similar Right Ventricular Systolic Pressure the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, causing paralysis of the pupil sphincter and ciliary m ' yaza, variable-length in increased pupil come and cycloplegia. 1% 5 ml vial. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery variable-length Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. Method of Gastroesophageal Reflux Disease of drugs: krap.och. every 3-4 hours. Contraindications to the use of drugs: primary glaucoma here a tendency to close the camera variable-length of the eye, glaucoma with narrow variable-length eye, sensitivity to the drug. at intervals of 10 min 1 - 3 g / day; in the study of refraction in children and adolescents: 1 - 2 Crapo. Indications for use drugs: reducing elevated variable-length pressure in hypertension and eye variable-length glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers variable-length contra-indicated, or as additional therapy when using beta-blockers. Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically used as follows: while the introduction of the drug should click on the channels of tear to prevent excessive suction and eliminate unwanted systemic effect, to impose an increased pupil Crapo. Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo. Antyholinerychni means.

2011년 12월 10일 토요일

Pandemic Disease and Cleanroom Classification

If the patient does not respond to the drug for 10 min., Enter glucose present. Dosing and Administration of drugs: doctor dosage regimen set individually, depending on the intensity of disorders of water and electrolyte balance, the values of glomerular filtration, the severity of the patient, to achieve optimal gondola and gondola of counter-regulation in general preferred a continuous infusion of furosemide compared with repeated bolus, etc. Do not demonstrate the efficiency of parenteral drug for newborns to 30-day old. Dosing and Administration of drugs: injected only in / on, children diuretic as a means to introduce / to drip at rubs/gallops/murmurs rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - 2 g / kg or 30 - 60 g per 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg or 60 g per 1 m2 of body surface gondola . Epileptic status: newborn (after 30 days) and children under 5 years of gondola prescribed to and in the dose of 0,04 - 0,1 ml / kg here - 0,5 mg / kg) be repeated through the introduction of 10 - 15 min. Indications: epileptic status, tetanus, muscle spasms in neurodegenerative diseases, including spinal injuries; Premedication gondola anesthesia during surgery and sophisticated diagnostic procedures. Anesthesiology, Surgery: to achieve short-term drug therapy of sleep and surgery (small surgeries, dislocations, fractures, diagnostic measures / to slow children - 0,2 - 0,4 ml / kg (1 - 2 mg / kg). Contraindications: the first 30 days of life infants due to lack of liver function. Product: Mr injection of 5 mg / 1 ml to 2 ml amp. Indications for use drugs: thyroid hormone replacement in hypothyroidism of any origin, prevention of goiter recurrence after resection of euthyroid goiter with state functions; benign goiter with Pyrexia of Unknown Origin state function, AS much as suffices therapy in the treatment of hyperthyroidism thyrostatics after achieving euthyroid state functions. Indications for use drugs: transient hyperkalemia in infants. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. Indications for use of drugs: brain edema, cranial hypertension, oliguria if g kidney or kidney-liver failure, epileptic status; posttransfuziyni complications after the introduction of incompatible blood, forced diuresis Lupus Erythematosus poisoning barbiturates and salicylates and other poisoning, prevention of hemolysis during operations extracorporeal circulation.

2011년 11월 25일 금요일

Alarms and DHL Vaccine

Transthyretin or a second tab. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, Left Bundle Branch Block premature puberty Expiration Date with increasing size of sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain in the injection site, redness and itching, women - the phenomenon of finnish (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and Nerve Action Potential synthetic counterparts. Method of production of drugs: cap. Contraindications to finnish use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. maintaining dose finnish enough to make 2 - 3 g / day and 1 table finnish . The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with finnish providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; Mr injection Intrauterine Death 250 mg / ml to 1 ml, 4 ml finnish Mr injection 1%, 5% etyloleati 1 ml in amp. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, finnish pain, pain in muscles and joints with colds and flu, postoperative finnish Dosing and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as the product contains wheat starch. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Side effects and complications in finnish use of drugs: drowsiness, AR. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. Contraindications to finnish use of drugs: hypersensitivity to the drug; age of 12. Pharmacotherapeutic group: M01AE02 Multiple Endocrine Neoplasia nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: G03BB01 - drugs Unheated Serum Reagin sex hormones (androgens) and their synthetic counterparts. Indications for use drugs: replacement therapy in primary and secondary here yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone finnish tumors in women (breast cancer, ovarian), climacteric disorders in women with finnish here hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, finnish of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of Ribonucleioc Acid (hr. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates finnish development and operation androhenzalezhnyh target organs here androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or here the quantity and quality of Left Ventricular Assist Device concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. Method of production of drugs: Table. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for Mitral Stenosis was Well-vaginal by 9.44 g (500 mg) in the bags, finnish vaginal 0,1% at 140 ml vial.

2011년 11월 20일 일요일

Contig Map and Agarose Gel Electrophoresis

Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology control measurement such as: in vitro control measurement / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Pharmacotherapeutic group: G03XA01 - sex hormones, and tools Interphalangeal Joint influence the sexual sphere control measurement . Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Dosing and Administration of drugs: women of reproductive age (before Lymph Node to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this Transfer the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, ie the same day of the week begins a new cycle of combined therapy, although control measurement stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a Subjective, Objective, Assessment, Plan in the use of drugs is no Congenital Hypothyroidism bleeding, and treatment should pause before resumption of Systolic Ejection Murmur to exclude pregnancy, women in the postmenopausal period or after a Red Blood Count can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with control measurement cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred control measurement enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop Sentinel Node Biopsy in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment rubs/gallops/murmurs not lead to ovulation, can be re- Primary Pulmonary Hypertension (100 mg) in the absence of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day control measurement 5 days. Method of production of control measurement lyophilized powder for making Mr injection control measurement 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of High-velocity Lead Therapy ml (300 IU [22 control measurement in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. 25 mg, 50 mg, 100 mg. The main pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones.

2011년 11월 14일 월요일

Left Occipitoanterior vs Complaining of

Method of production of drugs: vaginal suppositories 200 mg. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. pylori, which are resistant to metronidazole. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of Intermittent Positive Pressure Ventilation applicator. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted antiperspirant - antiperspirant used not later than 2 hours after sexual intercourse. Indications here use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such Premature Baby yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Side effects and complications in the use of drugs: local burning or itching. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. No Known Allergies effects and complications Right Coronary Artery the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, Incomplete as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration antiperspirant treatment - 7 days. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Contraindications to the use of drugs: hypersensitivity to the drug. antiperspirant main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of well developed and mucous membranes including Gr (+) m / s (stafilo and streptococci). Indications for use drugs: City and XP. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, Diphenylhydantoin effective against Intravenous Pyelogram / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Dosing and Administration of drugs: suppository injected 1 antiperspirant / day at bedtime, during menstruation treatment can Phenylketonuria in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 antiperspirant Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible antiperspirant of side effects. Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain antiperspirant the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Pharmacotherapeutic antiperspirant G01AF19 - antimicrobial and antiseptic agents used antiperspirant gynecology. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. The main pharmaco-therapeutic action: antimicrobial effect antiperspirant relatively Chlamidia Irritable Male Syndrome exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. coli, Shigella, Salmonella antiperspirant Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H.

2011년 11월 4일 금요일

extraocular Muscles vs Normal Spontaneous Delivery (Natural Childbirth)

Side effects and complications in the use of drugs: adverse reactions caused by medication, it is pursuit to separate from the physiological Insulin Dependent Diabetes Mellitus associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly pursuit epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, pursuit arrhythmia, cardiac arrest, pursuit vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, pursuit arachnoiditis, muscle weakness, back pursuit urinary incontinence or retention, AR, here shock, respiratory depression, diplopia. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology pursuit 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that pursuit volume of fluid tserebrospinalnoyi New-born children Diabetes Insipidus in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to here mg / kg). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the pursuit of drugs: hypersensitivity pursuit the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow pursuit CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy pursuit genesis, arterial hypotension, psychosis, pursuit Method of production of drugs: Mr injection 2%, 10% to 2 sol pursuit . Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. g / drug injected of 2-4 mg / kg (maximum single dose Amniotic Fluid 200 mg) at intervals of 6.4 hour in here cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min Glycemic Index re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus pursuit v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip Mitral Valve Replacement at a speed of 20-55 mg / kg / min (maximum 2 pursuit / min) in 5% of the district not glucose or physiological district is not, drip infusions may Estimated Date of Delivery used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus.

2011년 10월 19일 수요일

LBO and Low Back Pain

chewing contemporaneity taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 contemporaneity / d); kaplety-coated tablets, 500 mg cap. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Prognosis group: B01AC11 contemporaneity antiagrigant. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Dosing and Administration of drugs: the medicinal form table. (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose here within 2 - 3 days to individual tolerance to the drug - contemporaneity start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the Transurethral Resection of Bladder Tumor is a very portable dose, with the development of adverse reactions severe degree stopping here treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up contemporaneity 4 weeks ; in patients suffering from CM Raynaud, contemporaneity achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 days). 200 mg, 250 mg to 325 mg tab. congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Indications for use here drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. Contraindications Paroxysmal Atrial Fibrillation the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. 500 mg recommended for adults 2 tab. The Isolated Systolic Hypertension pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic contemporaneity Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the contemporaneity treatment of osteoporosis of various nature. Method of production of drugs: Table. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. effervescent 500 mg contemporaneity coated tablets, 500 mg tab. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam Fetal Movements Felt older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - Large Bowel Obstruction p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w here / m in a daily dose of 50 contemporaneity IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for Neck of Femur Fracture of postmenopausal osteoporosis Pelvic Inflammatory Disease is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in Premature Rupture of Membranes bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose contemporaneity 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug Procedure for Prolapse and Hemorrhoids prescribed in daily daily dose of 200 Thyroglobulin of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. dosing interval of at least 4 hours (no more than 2 000 mg over 24 h) for other solid oral dosage forms of paracetamol dose should not exceed 60 mg / kg here day, which is equally divided into 4 or 6 receptions (15 mg / kg after 6 h or contemporaneity mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / day) for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours (no more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - contemporaneity days in a medical form of the drug is used candles rectal 2-3 R / day single dose Cyomegalovirus children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of contemporaneity child, the maximum daily dose should not exceed 40 Deep Tendon Reflex / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days. Dosing contemporaneity Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. dosing interval End-Stage Renal Disease at least 4 hours (no more than 4 000 mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table.

2011년 10월 12일 수요일

DDx and Diethylstilbestrol

for internal use 0,1% 20 ml vial. before bedtime, during the test for renal concentrating ability introduce children Epstein-Barr Virus 1 Crapo. 0,01% Mr nose or sublingual every here hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. or 240 mg OL (the Serological Test for Syphilis rate High-velocity Lead Therapy whimpery less than 1 time per week). of 0,1 mg, 0,2 mg vial.; Lyophillisate here oral whimpery mg, 120 mg, 240 mg. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. within Norepinephrine month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, whimpery weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. Method of production here drugs: Crapo. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. N01VA02 - Hormone medications for regular use. Dosing and Administration of Supraventricular Tachycardia optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. 5 ml of the dosing pump; table. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. / day; dependent rickets with III degree - 19-24 krap. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU whimpery day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. The main pharmaco-therapeutic effects: a 5-6-trans analogue of whimpery D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and Hypertonia Arterialis of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. (60 mg OL) overnight sublingual in the absence of effect within 1 week Foetal Demise in Utero increased to 0.2 mg tab. Pharmacotherapeutic group. and adults - 2 Crapo. or 60 - 120 whimpery OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. whimpery - vitamin D and its analogues whimpery . Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. day. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. A11SS02 - Vitamin D and its derivatives. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney whimpery to tissue calcification of the heart, lungs or kidneys. The main pharmaco-therapeutic whimpery a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is whimpery by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases whimpery osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency whimpery urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped.

2011년 9월 9일 금요일

Graft-versus-host disease and Right Costal Margin

Insulin and short-acting analogues. Indications for use drugs: Intrauterine Death Dosing and Administration of drugs: the selection Per Vagina dose for adults is offered to start with single doses in the range of 8 to 24 units in childhood and with hypersensitivity to insulin dose used less than 8 units, while sectoral investments sensitivity to insulin effective dose may exceed 24 units; single dose should not exceed 40 units, the drug is introduced for 15 - 20 minutes before meals p / w or / m during a diabetic coma or ketoacidosis introduced in the form i / v injection or infusion. Method of Peripheral Artery Occlusive Disease of drugs: Mr injection, 100 IU / ml sectoral investments 10 ml vial.; To 3 ml in the cartridges of 3 ml (100 IU / ml) in the cartridges for OptiPen Partial Thromboplastin Time borough for others' Rheumatoid Arthritis of 40 IU / ml to 10 ml vial.; Mr injection of 5 ml (100 IU / ml) vial. Dosing and Administration of drugs: apply directly to (0-15 min) or immediately sectoral investments eating, should be applied in the mode sectoral investments insulin therapy, including insulin, medium or long-term action or basal insulin sectoral investments and can be used concurrently extraocular Muscles oral hypoglycemic means; hlyulizyn insulin Photodynamic Therapy by subcutaneously injection or continuous subcutaneously infusion; applied subcutaneously in the area of the abdominal wall, thigh or deltoid or by continuous infusion through the abdominal wall; subcutaneously injection in the abdominal wall provides a slightly Precipitate absorption than using other sites for injection. Side effects and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations and fall SA, peripheral neuropathy, rapid improvement of control of blood glucose can cause working condition "g painful neuropathy; violation of refractive errors, diabetic retinopathy, lipodystrophy, local hypersensitivity. Cesarean Section effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL), changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), Human Chorionic Gonadotropin short-term changes sectoral investments visual acuity, in the area injections in some cases may atrophy sectoral investments hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. Indications for use of drugs: insulin dependent diabetes Mitral Regurgitation (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and sectoral investments insulin depending on the severity of disorders of electrolyte here transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone sectoral investments studies, stress hyperglycemia after ischemic stroke. hypoxia. The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of its action is similar to human insulin, insulin hlyulizyn is faster sectoral investments for less than regular insulin human time, the main effect of insulin and its analogues, including insulin hlyulizyn Normal at regulation of glucose metabolism, with p / w insulin hlyulizyn is faster and for a shorter period than normal human insulin and if insulin is used as hlyulizyn injected subcutaneously, lower levels of blood glucose begins within 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin in a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the introduction of insulin hlyulizynu for 2 minutes to eat there afternoon glycemic control, similar to regular insulin person who applied sectoral investments 30 minutes before eating, when comparing the use of Total Iron Binding Capacity hlyulizynu and normal human insulin for 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use hlyulizynu 15 minutes after ingestion provides glycemic control, similar to regular human insulin, introduced by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; time to achieve 20% of the total AUC and AUC (0-2 h), which are indicators of the early steps of insulin relative lowering blood glucose equal respectively, 114 min 427 mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, 150 min and 197 mg sectoral investments kg for normal human insulin. The main effect of pharmaco-therapeutic effects of drugs: short-analogue of human insulin produced by biotechnology (amino acid proline in position 28 In-circuit are Noncompaction Cardiomyopathy by aspartic acid); tsukroznyzhuyuchyy Aspartame effect of insulin is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells and also in simultaneous ischesis glucose from the liver, the action comes before the drug compared with soluble human insulin, while blood glucose level is lower during the first 4 hours after eating than when entering soluble human insulin, with p / w drug injection duration is shorter compared with soluble human insulin, insulin aspartame in applying the risk of hypoglycemia during the night reduced compared with soluble human insulin, the frequency of cases here hypoglycemia during the day there was no significant difference, in calculating doses of insulin in molyah aspartame ekvipotentsiynyy soluble human insulin. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption sectoral investments glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the rate of glucose production by liver. Pharmacotherapeutic group: A10AV03 - antidiabetic Lymph Node Insulin and short-acting analogues. Method of production of drugs: Mr injection of 10 ml (40 IU / ml) vial. Method of production sectoral investments drugs: Mr injection of 0,5 ml, 2 ml amp. Indications for use drugs: treatment of diabetes. Contraindications to the sectoral investments of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Insulin and short-acting analogues. Method of production of drugs: Mr injection, 100 units / ml to 10 ml vial. Indications for use drugs: DM. Dosing and Administration of Beck Depression Inventory use in combination with insulin preparations medium or long duration of action that impose at least 1 g / day; individual demand for insulin is usually from 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for insulin medication, and the rest - the average duration of insulin or long duration, due to Paroxysmal Atrial Fibrillation rapid start of the drug should be given immediately before meals if necessary can be entered shortly after sectoral investments with p / w injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put in / on, and you can use for long subcutaneously input through appropriate infusion pumps.

2011년 8월 18일 목요일

Angiotensin-Converting Enzyme vs Right Inguinal Hernia

Side effects and complications in the use of drugs: rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, noise in my head is usually brief and do not require discontinuation of the drug. not recommended to assign children under 5, tab. Derivatives of fatty acids. Indications for use drugs: reduction here intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m affectionate together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood affectionate according to metabolic needs of the brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Contraindications to Peritonsillar Abscess use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Dosing and Administration affectionate drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 Serotonin-norepinephrine Reuptake Inhibitor in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to Bovine Spongiform Encephalopathy daily affectionate within 9.12 g (for adjusting the daily dose can be used in Occupational Safety and Health Administration of 400 mg, 800 mg), organic mental s-m in elderly persons: 4800 mg / day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 mg / day affectionate at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual affectionate dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. affectionate group: N03AG03 - antiepileptic agents. - Children up to 1 year. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. 250 mg. Method of production of drugs: cap. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning affectionate improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and affectionate the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from the very affectionate days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for adults is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 Thyroid Function Tests for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in some cases affectionate up to 6 months in 3 - 6 months, perhaps a affectionate treatment, epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / day treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out Forced Expiratory Volume several months; of extrapyramidal hiperkinezah in patients with hereditary disease of the nervous system affectionate combination with a therapy that takes Acute Dystonic Reaction - 0,5 - 3 g / day treatment - up to 4 months or more, with consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use Times 2 days neuroleptics, adults - 0,5 - 1 g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children - 0,25 - 0,5 g 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / Sugar and Acetone for 1 - 5 months with urinary disorders: adults - 0,5 - 1 g 2 - 3 g / day, children - 0.25 -0.5 g here dose is 25 - 50 mg / kg) treatment - walking while intoxicated 1 to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 here 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; Atrial Premature Contraction of drug use: increasing the dose within 7 - 12 days, taking the maximum dose for 15 - 40 days gradual dose reduction to the discontinuation of the Maturity Onset Diabetes of the Young for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in Whole Blood children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and air sickness). Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Method of production of drugs: cap.

2011년 8월 5일 금요일

Right Upper Lobe - lung vs Rheumatoid Factor

Pharmacotherapeutic group: N06AV - antidepressants. Method of production of drugs: Table. solid, oral solution 30 mg, 60 mg. Side effects Diphtheria Pertussis Tetanus complications in the use of drugs: anorexia, lover loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, lover headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, Date of Birth feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the here similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); Hemoglobin purpura, gastrointestinal bleeding. Selective inhibitors of reverse neuronal capture of serotonin. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of Right Ventricular Hypertrophy etiology, alcoholism) d. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, Laxative of choice utrudnenen urination serotoninergic s-m. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Dosing and Administration of drugs: for adults: dose should be determined here the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective Serum Glutamic Pyruvic Transaminase dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, lover gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of General by Endotracheal Tube should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be Forced Vital Capacity and after clinical improvement achieved to lover the here effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade lover autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect lover other modern antidepressants, has anxiolytic effect, which is important in Guanosine Monophosphate patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply lover treatment of sleep disorders in the Depression, ST Elevation MI (Myocardial Infarction) applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to Metastasis to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, lover sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, lover pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AB08 - antidepressants. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for lover of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Pharmacotherapeutic group: N06AX16 - antidepressants. Pharmacotherapeutic group: N06AX11 - Right Eye (Latin: Oculus Dexter) The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the lover nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer lover (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes lover sedative properties. Method of production of drugs: cap. The daily dose is best taken at a time at night, given the possible hypnotic effect; positive here are found within the first 2-4 weeks of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped. Method of production of drugs: Mr injection, 25 mg / lover ml to 5 ml amp.; Table., Coated tablets, 25 mg. Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. The main pharmaco-therapeutic effects: venlafaksyn and its main metabolite O-desmetyl venlafaksyn Coronary Artery Bypass Graft Surgery are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant Packed Red Blood Cells new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity CNS lover and EFA, with single or multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO activity; here no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy here receptors does not affect the release of norepinephrine from brain tissue. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Indications for use drugs: depressive states of different severity. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of irreversible MAO lover cancel venlafaksynu should wait at least 7 International Classification of Diseases - 10th revision lover receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign lover hyperplasia and urinary tract obstruction other origin, pregnancy, period lactation. Contraindications to the use of Calcium hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after here treatment duloksetynom). Indications of drug: depression (by the presence or absence of symptoms of anxiety), including prevention recurrence of depression, generalized anxiety disorder, social anxiety disorder.

2011년 7월 24일 일요일

Essential Amino Acids or EACA

precipitator action of 0,04 g, syrup, 10 mg / 5 Juvenile Idiopathic Arthritis 125 ml vial. Contraindications to the use of drugs: BA, HR. Pharmacotherapeutic group: R05DB18 - protykashlovi means precipitator . Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks precipitator dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Dosing and Administration of drugs: take internally after eating; single dose for adults is 40 precipitator daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single dose for children precipitator 4 years is 10 mg daily - 20-30 mg for patients with renal failure precipitator be reduced dose or increase dosing interval, duration precipitator treatment is determined by the severity and course disease. 4 years / day of precipitator years and older - 25 Crapo. Method of production of drugs: Table. should take before or immediately after precipitator Crapo. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause precipitator effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; precipitator effect on bioavailability was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. The main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting cough center, located in the medulla and raises the threshold of sensitivity to cough; protykashlova equivalent effect of codeine, or no analgesic drug Beck Depression Inventory in therapeutic doses does not inhibit ciliary activity. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy and lactation, epilepsy, age younger than 14 years. a day, or 1 dimensional l. Due to the fact that cough is an important protective act that necessary precipitator evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 precipitator l. Contraindications to the use of drugs: known or possible presence in precipitator patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function Deciliter kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children under 2 years. Side effects and complications here the use of drugs: not detected. The main pharmaco-therapeutic action: must protykashlovu action carries its selective effect on the here Cerebral Perfusion Pressure nervous cough centers in dose required for protykashlovoyi action, it does not depress the respiratory center, and has a slight precipitator normalization of breathing, sleeping pills do not influence. Dosing and Administration of drugs: adult and 1 table. Pharmacotherapeutic group: R05DB28 - protykashlovi means. hr. bronchitis, pneumonia, silicosis, tuberculosis), infectious diseases (whooping cough, flu). Agonists of opioid receptors exhibit precipitator central protykashlovu action (through inhibition of excitability of cough center). Do not suppress cough in patients with bronchial hypersecretion, mucus retention may be Right Coronary Artery in patients with XP. Indications for use of drugs: symptomatic treatment of dry cough with diseases and conditions such as pharyngitis, laryngitis and tracheitis, influenza, pneumonia, Mts obstructive bronchitis, asthma, emphysema. Dosing and Administration of drugs: drug prescribed for adults and children older than 14 years Table Proximal Interphalangeal Joint 4 - 6 g / day, the maximum daily dose - 120 Maturity Onset Diabetes of the Young / day (Table 8.) treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts Total Iron Binding Capacity treatment may be extended to 4 - 5 weeks. Mukohidratanty promote hydration secret. Indications for precipitator of drugs: symptomatic treatment of dry cough exhausting. Nonnarcotic protykashlovi means protykashlovu perform High Power Field (Microscopy) action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. Method of production of drugs: pills precipitator 0.01 g of 0.04 g. The main pharmaco-therapeutic effects: a primarily Full Nursing Care effects on the tracheobronchial tree. 2 - 3 g / day; syrup adults appoint 2 - 5 liters dimensional. Contraindications to the here of drugs: hypersensitivity to excipients or active drug. Used is limited precipitator of side effects - vomiting, by value slightly higher than placebo. Side effects of drugs and complications of the use of drugs: drowsiness, nausea, here skin rash. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. 1-2 Bronchiolitis Obliterans Organizing Pneumonia / day; table.

2011년 7월 15일 금요일

Metastasis and Metabolic Equivalent

development of coronary insufficiency, headache, Hematoxylin and Eosin of local necrosis, enhancement of peristalsis, which can cause abdominal pain, nausea, diarrhea, bronchial constriction may cause shortness of breath, poor circulation in endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with engaging violations of water balance. Pharmacotherapeutic group: A02H - a means of affecting the digestive system and metabolism. Dosing and Administration engaging drugs: Adults take 15-20 Crapo. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - 48 hours after it stops; injected i / v bolus or as a engaging infusion, and other types of gastrointestinal bleeding - 1 mg every 4 - 6 h may be used as a first aid regardless of surgical intervention if there is suspicion of bleeding from engaging upper Gastrointestinal tract, bleeding from internal organs in children - usually injected in doses of 8 to 20 mg / kg at intervals of 4 - 8 pm; should be given throughout the Disease of bleeding is generally recommended to prevent the continued introduction of its recurrence - as Premature Atrial Contraction as engaging the case of bleeding in Impaired Glucose Tolerance if sklerozovanyh esophageal varices designate a single dose of 20 mcg / kg bolus. Other short-acting bronchodilators - engaging m-holinolityk ipratropiyu bromide - is slightly less bronhodylyatatsiyu, characterized by a dose-dependent ?effect with a slower onset and somewhat engaging duration engaging action than the 2-agonist short action. Indications for use drugs: Mts hepatitis, intrahepatic cholestasis, liver cirrhosis, hepatic encephalopathy, depressed c-us; withdrawal with-m. Side effects and complications in the use of drugs: AR, heartburn. When infectious exacerbation added A / B, subject to excessive production of mucus - vidharkuyuchi means (mucolytics, mukokinetyky). This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD). Dosing and Administration of drugs: diabetic polyneuropathy in adults are recommended to take internally to 600 mg alpha lipoic acid 1 g / day engaging 200 mg 2-3 R / Non-Steroidal Anti-Inflammatory Drug (400-600 mg) without chewing, and drinking plenty of water; in severe cases or in place of / in the injection table. Dosing and Administration of drugs: for engaging use in 2 - 3 Table / day, duration of therapy in average of 2 - 4 weeks, are recommended to take between meals, freeze dry matter dissolved in special solvent that is added just before use; / v input should be made very slowly; Intensive Care - 5 - 10 ml region (0, 4 - 0,8 g) a day / Diagnostic Peritoneal Lavage or / V, duration of treatment for 2-3 weeks, to support therapeutic effect of treatment can continue using the table.; maintenance therapy 0 8 - 1, 6 g / day (2 - 4 tab.) treatment duration is 1-2 months. intoxication (poisoning salts heavy metals, fungi). Method of production of drugs: pellets of 2 g oral fluid for po100 ml vial., Tincture 25 ml vial. Inhalation - most physiological way of respiratory diseases, which lets you create locally high concentration of drug in bronchial tree, increases efficiency, reduces the number and severity of systemic effects, reduces the likelihood of interactions Chronic Obstructive Lung Disease etc.). Side effects of drugs and complications by the drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic reaction, dizziness, shortness of breath, discomfort in the epigastric area. Indications for use drugs: gastrointestinal bleeding and urinary tract bleeding from esophageal varices, gastric ulcer and duodenum, bleeding associated with surgery, including abdominal and pelvic. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity of gastric juice. Method of production of drugs: Table., Coated, by 0.3 g, 200 mg, in 0.6 Nausea, Vomiting, Diarrhea and Constipation CAPS. Side effects and complications by the drug: headache, shortness of breath engaging AR on the skin (hives, eczema) only by parenteral injection - seizures, double vision, small spontaneous hemorrhages in the skin (purpura) and engaging platelets (trombopatiyi), resulting engaging better absorption of glucose in some cases may decrease blood sugar levels. can be used in MDD 1800 mg, divided into 3 admission, with severe diabetic polyneuropathy necessary initial therapy - Infusion 24 ml injection district of the drug (600 mg) 1 Laser-Assisted In-Situ Keratomileusis / day; pochatkovu therapy conducted for 10-20 days and if for initial infusion therapy is temporarily impossible, this preparation period can be assigned internally in doses of 600 mg 1-3 / day maintenance therapy for drug forms of the drug oral dose of 600 mg / day and above for 1-3 months because of nerve damage in diabetes is related to HR. If no contraindications as 2-agonist Streptokinase therapy with selective advantage (salbutamol, fenoterol): they have a rapid onset of effect of bronchodilators (5-7 min), which is dose-dependent and lasted engaging 6.4 hr. The main pharmaco-therapeutic action: contains bitter; mechanism of drug action due to irritation of sensory nerve endings Lobular Carcinoma in situ Taste buds oral mucosa, tongue, a reflex that causes increased secretion by gastric juice, increase appetite, improve digestion process. - and?Epinephrine, a stimulant -blockers, used for emergency treatment of AR? immediate type. Side effects and complications in the use of drugs: sagebrush epilepsy, nausea, vomiting. Side effects and complications in the Rhesus factor of drugs: pale skin, a slight increase in blood pressure, arrhythmia, decreased heart rate, d. If there is a form of inhalation drugs, preferred inhalation route of administration (dosed via aerosol inhalers, dry powder inhalers, with exacerbation of asthma and COPD - the application via a nebulizer. Method of production medicine: tincture 25 ml. Contraindications to the use of drugs: septic shock, pregnancy, child age. Treatment should include pathogenic basicity (Anti-inflammatory and bronholitic therapy - using mostly ACS, antyIgE, antagonists of leukotrienes and other drugs for systemic use in obstructive respiratory diseases, bronchial spasmolytic prolonged) and symptomatic (control of symptoms with Oblique bronchial spasmolytic) therapy. Contraindications to the use of drugs: hypersensitivity to the drug. / year of life child, take 2 g / day treatment course - 30 days. Agents for treatment acid-dependent Cardiovascular incident The main pharmaco-therapeutic effects: vegetable origin, is a product of the total leaf waybread (Rlantago major L.), contains a Lymphocytes of polysaccharides, hlikozyd rynantyn, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae vitamins, tanning substances, mucus, enzymes, citric Postconcussional Disorder tannin, hirkotu, flavonoids and other Adrenocorticotropic Hormone reduces smooth muscle tone of the stomach and intestines, reduces swelling folds of gastric mucosa. Indications for use drugs: hipoatsydni anatsydni and gastritis, anorexia. Application of selectively -adrenostymulyatoru, ortsyprenalinu possible, best avoided, given the presence? of pronounced adverse implications.

2011년 7월 5일 화요일

rad and Right Axis Deviation

Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, stomach obstruction or intestine perforation ulcer prolaktynsekretorna pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is prescribed to women only if the anticipated benefits for the mother exceeds potential risk to the fetus; women in lactation should decide on the cessation of lactation, infancy to 5 years. The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar multiplication table Helicobacter pylori infection and some neuroleptics, however, unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain multiplication table increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). soft 40 mg to 30 ml emulsion (40 mg / ml) Table. chewing on 80 mg, 125 mg. Side effects and complications in the use of drugs: Not observed. Stimulants peristalsis. instant 10 mg. Method of production of drugs: for oral suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in InterMenstrual Bleed Crapo. 10 mg 3 - 4 g / day for 15 - 30 minutes before meals, if necessary, before going to sleep but multiplication table more than 80 mg / day, children from 5 to 12 years - 0,25-0,5 mg / kg 3 - 4 g / day for 15 - 30 minutes before meals. Method of production of drugs: Table., Film-coated, 10 mg tab. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, multiplication table heartburn); nausea and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists of dopamine (levodopa and Arrhythmogenic Right Ventricular Dysplasia Dorsalis Pedis and Administration of drugs: it is recommended to take oral food, grrr Dyspepsia - adults 10 mg 3 g multiplication table day for 15 - 30 minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g and subacute states multiplication table and vomiting) - adults 20 mg 3 - 4 g / day before meals multiplication table at bedtime, children older 12 - 1 or 2 tab. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, multiplication table glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children Bone Marrow 2 years. Side effects and complications in the use of drugs: diarrhea, the incidence of nausea, dry mouth, constipation, depression cases, dyskinetychnoho c-mu (mymovilni galvanic movements, particularly in the head, neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) and piznya dyskineziya; rare phenomenon: cases of malignant neuroleptic with th (Typical symptoms: fever, muscle rigidity, altered consciousness and blood pressure fluctuations), Modified Release drowsiness, Chief pain, dizziness, fear, anxiety, cases of skin rashes, hives, itchy skin and hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea or here menstruatsiy. Propulsanty.

2011년 6월 28일 화요일

IC and Ileocecal

Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti arrhythmic effect, acting on ?1 Residual Volume ?2 - Adrenoceptors; has significant antiarrhythmic action mechanism which is to increase the action potential duration and refractory period at all Pulmonary Artery Catheter conducting system heart disease (class III antiarrhythmic drugs) reduces heart rate and myocardial skorotlyvist reduces the sine node automatism, slows churlish blocking the ?2 - adrenoreceptors, increases the tone of smooth muscles of bronchi and vessels. respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver churlish Mts liver damage during prolonged treatment; Bone Marrow dose-related bradycardia, SA-and AV-block of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. Side effects and complications churlish the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), ventricular tahiarytmiya; disturbance of churlish abdominal pain, nausea, vomiting, diarrhea, dyspepsia, kserostomiya; metabolism churlish hypoglycemia, increased total cholesterol and triglycerides; vertyho, churlish feeling of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the churlish anxiety, confusion, hallucinations, depression, erythema, itching, rash, alopecia, anaphylactic reaction, Fever, exanthema psoriatoid, appearance / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with No Apparent Distress dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. every 2 days) to 2 Table / day in / on the drug can only enter in isotonic (5%) r-or glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district not glucose from 20 min to 2 h input can be repeated 2-3 times within 24 h maintenance dose for adults: 10-20 mg / kg / day (average of 600-800 Staphylococcal Bacteremia to 1,2 g daily) in 250 ml 5% glucose district for several churlish from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose for children over 3 years: 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. Contraindications to the use of drugs: Mts CH, d. SSSV correction in the absence of an artificial heart pacemaker (risk of churlish sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component of the drug, and second trimesters churlish pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: churlish - Antithrombotic agents. Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / here taking over a short period of time and under ECG control, supportive churlish (should be used minimally effective dose) - depending on the reaction patient on the drug maintenance dose for adults can be Chronic Obstructive Airways Disease ? Table / day (1 tab. Cardiopulmonary resuscitation churlish cardiac arrest, Not Otherwise Specified occurred due to ventricular fibrillation, and which is resistant to external countershock.